Literature DB >> 16170802

Model peptides mimic the structure and function of the N-terminus of the pore-forming toxin sticholysin II.

Fábio Casallanovo1, Felipe J F de Oliveira, Fernando C de Souza, Uris Ros, Yohanka Martínez, David Pentón, Mayra Tejuca, Diana Martínez, Fabiola Pazos, Thelma A Pertinhez, Alberto Spisni, Eduardo M Cilli, María E Lanio, Carlos Alvarez, Shirley Schreier.   

Abstract

To investigate the role of the N-terminal region in the lytic mechanism of the pore-forming toxin sticholysin II (St II), we studied the conformational and functional properties of peptides encompassing the first 30 residues of the protein. Peptides containing residues 1-30 (P1-30) and 11-30 (P11-30) were synthesized and their conformational properties were examined in aqueous solution as a function of peptide concentration, pH, ionic strength, and addition of the secondary structure-inducing solvent trifluoroethanol (TFE). CD spectra showed that increasing concentration, pH, and ionic strength led to aggregation of P1-30; as a consequence, the peptide acquired beta-sheet conformation. In contrast, P11-30 exhibited practically no conformational changes under the same conditions, remaining essentially structureless. Moreover, this peptide did not undergo aggregation. These differences clearly point to the modulating effect of the first 10 hydrophobic residues on the peptides aggregation and conformational properties. In TFE both the first ten hydrophobic peptides acquired alpha-helical conformation, albeit to a different extent, P11-30 displayed lower alpha-helical content. P1-30 presented a larger fraction of residues in alpha-helical conformation in TFE than that found in St II's crystal structure for that portion of the protein. Since TFE mimics the membrane environment, such increase in helical content could also occur upon toxin binding to membranes and represent a step in the mechanism of pore formation. The peptides conformational properties correlated well with their functional behavior. Thus, P1-30 exhibited much higher hemolytic activity than P11-30. In addition, P11-30 was able to block the toxin's hemolytic activity. The size of pores formed in red blood cells by P1-30 was estimated by measuring the permeability to PEGs of different molecular mass. The pore radius (0.95 +/- 0.01 nm) was very similar to that of the pore formed by the toxin. The results demonstrate that the synthetic peptide P1-30 is a good model of St II conformation and function and emphasize the contribution of the toxin's N-terminal region, and, in particular, the hydrophobic residues 1-10 to pore formation. Copyright 2005 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16170802     DOI: 10.1002/bip.20374

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  11 in total

1.  The membranotropic activity of N-terminal peptides from the pore-forming proteins sticholysin I and II is modulated by hydrophobic and electrostatic interactions as well as lipid composition.

Authors:  Uris Ros; Lohans Pedrera; DaylÍn Diaz; Juan C De Karam; Tatiane P Sudbrack; Pedro A Valiente; Diana MartÍnez; Eduardo M Cilli; Fabiola Pazos; Rosangela Itri; Maria E Lanio; Shirley Schreier; Carlos Ávarez
Journal:  J Biosci       Date:  2011-12       Impact factor: 1.826

2.  Effects of dimerization on the structure and biological activity of antimicrobial peptide Ctx-Ha.

Authors:  E N Lorenzón; G F Cespedes; E F Vicente; L G Nogueira; T M Bauab; M S Castro; E M Cilli
Journal:  Antimicrob Agents Chemother       Date:  2012-03-05       Impact factor: 5.191

3.  Membrane Remodeling by the Lytic Fragment of SticholysinII: Implications for the Toroidal Pore Model.

Authors:  Haydee Mesa-Galloso; Pedro A Valiente; Mario E Valdés-Tresanco; Raquel F Epand; Maria E Lanio; Richard M Epand; Carlos Alvarez; D Peter Tieleman; Uris Ros
Journal:  Biophys J       Date:  2019-09-20       Impact factor: 4.033

Review 4.  Biophysical and biochemical strategies to understand membrane binding and pore formation by sticholysins, pore-forming proteins from a sea anemone.

Authors:  Carlos Alvarez; Uris Ros; Aisel Valle; Lohans Pedrera; Carmen Soto; Yadira P Hervis; Sheila Cabezas; Pedro A Valiente; Fabiola Pazos; Maria E Lanio
Journal:  Biophys Rev       Date:  2017-08-29

5.  Molecular basis for membrane pore formation by Bax protein carboxyl terminus.

Authors:  Suren A Tatulian; Pranav Garg; Kathleen N Nemec; Bo Chen; Annette R Khaled
Journal:  Biochemistry       Date:  2012-11-12       Impact factor: 3.162

6.  Half a century deciphering membrane structure, dynamics and function: a short description of the life and research of Shirley Schreier.

Authors:  Shirley Schreier
Journal:  Biophys Rev       Date:  2021-11-13

Review 7.  Actinoporins: From the Structure and Function to the Generation of Biotechnological and Therapeutic Tools.

Authors:  Santos Ramírez-Carreto; Beatriz Miranda-Zaragoza; Claudia Rodríguez-Almazán
Journal:  Biomolecules       Date:  2020-04-02

8.  Identification of a pore-forming protein from sea anemone Anthopleura dowii Verrill (1869) venom by mass spectrometry.

Authors:  Santos Ramírez-Carreto; Erick I Pérez-García; Sandra I Salazar-García; Johanna Bernáldez-Sarabia; Alexei Licea-Navarro; Enrique Rudiño-Piñera; Leonor Pérez-Martínez; Gustavo Pedraza-Alva; Claudia Rodríguez-Almazán
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2019-02-11

9.  Dissecting the mechanism of action of actinoporins. Role of the N-terminal amphipathic α-helix in membrane binding and pore activity of sticholysins I and II.

Authors:  Gustavo P B Carretero; Eduardo F Vicente; Eduardo M Cilli; Carlos M Alvarez; Håvard Jenssen; Shirley Schreier
Journal:  PLoS One       Date:  2018-08-30       Impact factor: 3.240

10.  Antimicrobial activity of RP-1 peptide conjugate with ferrocene group.

Authors:  Natalia C S Costa; Julia P Piccoli; Norival A Santos-Filho; Leandro C Clementino; Ana M Fusco-Almeida; Sarah R De Annunzio; Carla R Fontana; Juliane B M Verga; Silas F Eto; João M Pizauro-Junior; Marcia A S Graminha; Eduardo M Cilli
Journal:  PLoS One       Date:  2020-03-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.